Loading search results
ChANGE HD
Growth and Development of Striatal-Cerebellum Circuitry in Subjects at Risk for Huntington's Disease
Sponsor study identifier
Secondary identifiers
observational
488
1 country
6
Study Start
July 2005
Actual (reported)Primary Completion
March 31, 2026
Actual (reported)Study Completion
March 31, 2026
Actual (reported)Huntington's Disease (HD) is an autosomal dominant disease manifested in a triad of cognitive, psychiatric, and motor signs and symptoms. HD is caused by a triplet repeat (CAG)expansion in the gene Huntingtin (HTT). This disease has classically been conceptualized as a neurodegenerative disease. However, recent evidence suggests that abnormal brain development may play an important role in the etiology of HD. Huntingtin (HTT)is expressed during development and through life. In animal studies, the HTT gene has been shown to be vital for brain development. This suggests that a mutant form of HTT (gene-expanded or CAG repeats of 40 and above) would affect normal brain development. In addition, studies in adults who are gene-expanded for HD, but have not yet manifested the illness, (pre-HD subjects) have significant changes in the structure of their brain, even up to 20 years before onset of clinical diagnosis. How far back these changes are evident is unknown. One possibility is that these brain changes are present throughout life, due to changes in brain development,though initially associated with only subtle functional abnormalities. In an effort to better understand the developmental aspects of this brain disease, the current study proposes to evaluate brain structure and function in children, adolescents, and young adults (ages 6-30) who are at risk for developing HD - those who have a parent or grandparent with HD. Brain structure will be evaluating using Magnetic Resonance Imaging (MRI) with quantitative measures of the entire brain, cerebral cortex, as well as white matter integrity via Diffusion Tensor Imaging. Brain function will be assessed by cognitive tests, behavioral assessment, and physical and neurologic evaluation. Subjects that are gene-expanded (GE) will be compared to subjects who are gene non-expanded (GNE). Changes in brain structure and/or function in the GE group compared to the GNE group would lend support to the notion that this disease has an important developmental component.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 31, 2026
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2005
Actual (reported)May 16, 2013
Actual (reported)May 22, 2013
Actual (reported)March 31, 2026
Actual (reported)March 31, 2026
Actual (reported)Volume of brain structures as measured by Magnetic Resonance Imaging (MRI)
Magnetic Resonance Imaging (MRI) and Diffusion Tensor Imaging (DTI) data will be analyzed to assess brain structure based upon variables including global volume, total cerebral spinal fluid, subregion volumes, cortical surface anatomy including cortical depth, surface area and gyral shape, and symmetry between brain hemispheres, all in consideration of age, gender, and height. Results will be evaluated for comparative differences between the GE group and the GNE group. In addition, these measures of brain structure will be paired with corresponding measures of brain function to evaluate brain development based upon growth and performance.
1 hour out of 6-7 hour testing day, 3-4 annual visits
Quantitative assessment of cognitive skills and behavioral factors
4 hours out of 6-7 hour testing day, 3-4 annual visits
Quantitative assessment of motor performance
1 hour out of 6-7 hour testing day, 3-4 annual visits
Quantification of Neurofilament Light
10 minutes for blood draw out of 6-7 hour testing day, 3-4 annual visits
Children at risk for HD who have a CAG repeat length of 40 and above.
Children at risk for HD who have a CAG repeat length of 39 or less
Young people ages 6-30 years old who have a parent or grandparent that has been diagnosed with Huntington's Disease
University of California Davis
Sacramento, California, 95817, United States
University of Iowa Hospitals and Clinics, Department of Psychiatry
Iowa City, Iowa, 52242, United States
Columbia University Medical Center
New York, New York, 10027, United States
Children's Hospital of Philadelphia with the University of Pennsylvania
Philadelphia, Pennsylvania, 19146, United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Bio-specimens are collected and retained for all participants for genetic testing purposes and future research. Specimens are a single sample of 3-4 teaspoons of blood drawn from the arm. Optional saliva sample collection will be offered if unable to collect sufficient blood sample. Biospecimens will be tested for the number of CAG repeats in the Huntingtin Gene. Each sample obtained will be coded with a randomly assigned number and never linked with personal identifiers. The results from the genetic analysis will be sent directly to the data manager on the project, who is the ONLY research member with access to this data. This person has no direct contact with study participants.
Peggy C Nopoulos, MD
University of Iowa
488 participants (actual enrollment reported by the registry).
First Submitted
May 16, 2013
First Posted
May 22, 2013
Study Start
July 2005
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
March 31, 2026
Actual (reported)Study Completion
March 31, 2026
Actual (reported)Last Updated
April 30, 2026
Record last verified: 2026-04
Aggregate, de-identified data may be shared with approved collaborators, but individual participant data will not be shared.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: